Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
University College London · Semmelweis University · +17 more institutions
Abstract
Many treatments have been identified that confer robust cardioprotection in experimental animal models of acute ischemia and reperfusion injury. However, translation of these cardioprotective therapies into the clinical setting of acute myocardial infarction (AMI) for patient benefit has been disappointing. One important reason might be that AMI is multifactorial, causing cardiomyocyte death via multiple mechanisms, as well as affecting other cell types, including platelets, fibroblasts, endothelial and smooth muscle cells, and immune cells. Many cardioprotective strategies act through common end-effectors and may be suboptimal in patients with comorbidities. In this regard, emerging data suggest that optimal…
Citation impact
- FWCI
- 56.46
- Percentile
- 100%
- References
- 68
Authors
11Topics & keywords
- Cardioprotection
- Medicine
- Reperfusion injury
- Myocardial infarction
- Ischemia
- Cardiology
Funding
- SFStrategiske ForskningsrådAward: 11-108354
- NINational Institute for Health and Care Research
- UCUniversity College London
- DFDeutsche ForschungsgemeinschaftAwards: CRC 1213, CA16225, SFB 1116
- ANAgence Nationale de la RechercheAwards: ANR-16-RHUS-0009, ANR-10, ANR-10-IBHU-0004
- SESemmelweis EgyetemAwards: NVKP_16-1-2016-0017, CA16225
- HSHungarian Scientific Research FundAward: 115378
- NNNovo Nordisk
- EEEmberi Eroforrások Minisztériuma
- TTrygFondenAward: 11-108354
- EEU-CARDIOPROTECTIONAward: CA16225
- NRNational Research, Development and Innovation OfficeAward: NVKP_16-1-2016-0017